The next item of business is consideration of business motion S3M-2626, in the name of Bruce Crawford, on behalf of the Parliamentary Bureau, setting out a business motion.
Motion moved,
That the Parliament agrees—
(a) the following programme of business—
Wednesday 8 October 2008
2.30 pm Time for Reflection
followed by Parliamentary Bureau Motions
followed by First Minister's Statement: Scottish Broadcasting Commission
followed by Scottish Government Debate: Scottish Broadcasting Commission
followed by Business Motion
followed by Parliamentary Bureau Motions
5.00 pm Decision Time
followed by Members' Business
Thursday 9 October 2008
9.15 am Parliamentary Bureau Motions
followed by Local Government and Communities Committee Debate: 8th Report 2008: Elections 2007
11.40 am General Question Time
12 noon First Minister's Question Time
2.15 pm Themed Question Time
Finance and Sustainable Growth
2.55 pm Ministerial Statement: Strengthening Scotland's Secure Accommodation
followed by Parliamentary Bureau Motions
followed by Stage 3 Proceedings: Scottish Register of Tartans Bill
followed by Parliamentary Bureau Motions
5.00 pm Decision Time
followed by Members' Business
Wednesday 29 October 2008
2.30 pm Time for Reflection
followed by Parliamentary Bureau Motions
followed by Scottish Government Business
followed by Business Motion
followed by Parliamentary Bureau Motions
5.00 pm Decision Time
followed by Members' Business
Thursday 30 October 2008
9.15 am Parliamentary Bureau Motions
followed by Scottish Government Business
11.40 am General Question Time
12 noon First Minister's Question Time
2.15 pm Themed Question Time
Europe, External Affairs and Culture;
Education and Lifelong Learning
2.55 pm Scottish Government Business
followed by Parliamentary Bureau Motions
5.00 pm Decision Time
followed by Members' Business
and (b) that the period for members to submit their names for selection for General and Themed Question Times on 30 October 2008 should end at 12.00 noon on Wednesday 8 October.—[Bruce Crawford.]
Motion agreed to.
Previous
Cancer Drug Access